Pulmonary embolism

3,501 views 30 slides May 07, 2016
Slide 1
Slide 1 of 30
Slide 1
1
Slide 2
2
Slide 3
3
Slide 4
4
Slide 5
5
Slide 6
6
Slide 7
7
Slide 8
8
Slide 9
9
Slide 10
10
Slide 11
11
Slide 12
12
Slide 13
13
Slide 14
14
Slide 15
15
Slide 16
16
Slide 17
17
Slide 18
18
Slide 19
19
Slide 20
20
Slide 21
21
Slide 22
22
Slide 23
23
Slide 24
24
Slide 25
25
Slide 26
26
Slide 27
27
Slide 28
28
Slide 29
29
Slide 30
30

About This Presentation

Pulmonary Embolism in a nutshell


Slide Content

PULMONARY EMBOLISM Dr.Partha Das MEM,PGY2 Fortis Hospital, Kolkata 08/04/2016

STATISTICS (INDIAN SCENARIO) Overall, the annual incidence of PE ranges between 23 and 69 cases per 100,000 population  Responsible for up to 15% of all in-hospital deaths Accounts for 20 to 30% of deaths a/w pregnancy & delivery Average case fatality rate within 2 weeks of Δ of ~ 11 % Roughly accounting for at least 100,000 deaths each year Ref : indian heartjournal.com/ihj09/sep_oct_09/467-469.html

DEFINITION Refers to the obstruction of the pulmonary artery or one of its branches by a thrombus (or thrombi) that originates somewhere in the venous system or in the right side of the heart

PATHOPHYSIOLOGY Embolization Impaired gaseous exchange Increased pulmonary vascular resistance Increased airway resistance Decreased pulmonary compliance

Contd … As pulmonary vascular resistance↑, RV wall tension ↑ & causes further RV dilation & dysfunction ↓ ↑ RV wall tension also compresses the RCA ↓ ↓ subendocardial perfusion & limits myocardial oxygen supply ↓ Provokes MI → eventually circulatory collapse & death may ensue Ref : Harrison’s Principles of Internal Medicine, 18 th Ed

PREDISPOSING FACTORS Malignancy Prolonged bed rest Long-haul air travel Obesity COPD Systemic arterial HTN Smoking OCPs Pregnancy Surgery & trauma Post menopausal hormone replacement Thrombophilia, AF

HEREDITARY FACTORS Antithrombin III deficiency Protein C deficiency Protein S deficiency Factor V Leiden Plasminogen abnormality Fibrinogen abnormality Resistance to activated Protein C

VIRCHOW’S TRIAD

CLINICAL FEATURES Dyspnoea (m/c) Pleuritic chest pain (sudden & sharp) Substernal chest pain Cough Fever Hemoptysis Syncope Unilateral leg pain (signs of DVT) Diaphoresis Tachycardia, Tachypnoea Hypoxemia (paO2 < 8ommHg ) S 3 or S 4 gallop/cardiac murmur

Well’s Score For PE HR > 100 1.5 Hemoptysis 1 H/o previous TE 1.5 Active malignancy 1 Signs of DVT 3 Risk for PE >6 = High risk 2-6 = Moderate risk <2 = Low risk

PE Severity Index (PESI) Predictors Points Age +1 per year Male sex +10 Heart Failure +10 Chronic Lung disease +10 Art. O 2 sat. <90 % +20 Pulse >110bpm +20 RR>30/min +20 T˚<36˚C/96.8˚F +20 Cancer +30 SBP<100mmHg +30 Altered mentation +60

Contd… Score Risk Class <65 I 66-85 II 86-105 III 106-125 IV >125 V *Low prognostic risk is defined as ≤ 85 points

PE R/O Criteria (PERC) Age < 50 years HR < 100 bpm S p O 2 >95% in R/A No Hemoptysis No exogenous Estrogen use No previous TE No trauma/Surgery requiring hospitalization (in 4 weeks) No U/L leg swelling

DIAGNOSTIC FINDINGS Chest X Ray Radiographic signs include:- Fleishner sign : enlarged pulmonary artery (20%) Hampton hump :  peripheral wedge of airspace opacity and implies lung infarction (20%) Westermark's sign :  regional oligaemia and highest positive predictive value (10%) Pleural effusion  (35%) Knuckle sign   Ref : http://radiopaedia.org/articles/pulmonary-embolism

Contd… ECG Sinus tachycardia  –  m/c abnormality Complete or incomplete RBBB –  a/w ↑ mortality RV strain pattern –  T wave ↓ in the right precordial leads (V1-4) ± the inferior leads Right axis deviation Right atrial enlargement (P pulmonale ) – peaked P wave in lead II > 2.5 mm in height Atrial Tachyarrhythmias –  AF, Flutter Non specific ST-segment & T wave changes

Contd… CT Pulmonary Angiography (CTPA) filling defects within the pulmonary vasculature with acute pulmonary emboli When observed in the axial plane this has been described as the polo mint sign

Contd…

Other Investigations :- ECHO - It helps to detect RV enlargement & RWMA a/w PTE ( McConnell’s sign - hypokinesia of RV free wall with normal motion of RV apex is best known indirect sign of PE ) ABG - ↓ P a O 2 D- Dimer assay NT Pro BNP V/Q Scan Venous USG & Impedence Plethysmography Contrast enhanced Helical CT Lung

Diagnostic Approach

Management Provide O 2 by cannula/mask/ventilator – as indicated Elevate head-end of bed Elevate lower extremities if DVT is present Morphine to manage pain & anxiety (avoid in case of severe Hypotension) Inj. Heparin 10,000 U i /v bolus followed by 5000 U i /v 6 hourly charged in 200 ml N/S LMWH (Enoxaparin 1mg/kg BD s/c) Dopamine or Dobutamine infusion to treat hypotension & shock

Different LMWH in use Name Treatment Dose Enoxaparin 1 mg/kg twice daily (approved as an inpatient or outpatient dose), or 1.5 mg/kg once daily (inpatient dose only) Dalteparin 100 units/kg twice daily, or 200 units/kg once daily Tinzaparin 175 units/kg once daily

Pulmonary Embolectomy Emergency surgical removal of emboli which are blocking blood circulation & causing necrosis

Vena Cava Filter Type of vascular filter, a medical device that is implanted into the inferior vena cava to presumably prevent life-threatening pulmonary emboli

Prevention Leg exercises (Dorsiflexion of feet) Frequent position changes Ambulation Intermittent pneumatic leg compression devices Anti embolism stockings Tab.Warfarin 5mg BD x 3-4 weeks & then can be tapered to keep INR @ 2.5-3

REFERENCES Tintinalli’s Emergency Medicine e-Book 6 th Edition Harrison’s Principles of Internal Medicine 18 th Edition European Heart Journal, 2014 Kapoor VK. Venous thromboembolism in India. The National Medical Journal. 2010;23(4):193-95 . European Heart Journal Advance Access published August 29, 2014 radiopaedia.org/articles/pulmonary-embolism
Tags